omega-n-methylarginine has been researched along with telmisartan in 3 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (telmisartan) | Trials (telmisartan) | Recent Studies (post-2010) (telmisartan) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,930 | 480 | 1,038 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | telmisartan (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.42 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0179 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0003 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 0.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.2589 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8621 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellien, J; Bourkaib, R; Eltchaninoff, H; Iacob, M; Joannides, R; Thuillez, C | 1 |
| Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ | 1 |
| Barini, A; Cardillo, C; Di Daniele, N; Mores, N; Schinzari, F; Tesauro, M; Veneziani, A | 1 |
2 trial(s) available for omega-n-methylarginine and telmisartan
| Article | Year |
|---|---|
AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspirin; Benzimidazoles; Benzoates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Fluconazole; Humans; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Radial Artery; Regional Blood Flow; Telmisartan; Vascular Resistance; Vasodilation; Vasodilator Agents | 2007 |
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance | 2009 |
1 other study(ies) available for omega-n-methylarginine and telmisartan
| Article | Year |
|---|---|
Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity.
Topics: Acetylcholine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Annexins; Apelin; Benzimidazoles; Benzoates; Endothelium, Vascular; Female; Forearm; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nitric Oxide; Nitroprusside; Obesity; omega-N-Methylarginine; Pyridines; Regional Blood Flow; Telmisartan; Vasodilation | 2017 |